Skip to main content

Life Sciences

Mayer Brown is a leading provider of legal services to a broad range of participants in the global pharmaceuticals, biotech and medical device industries.

  • AddRemove
  • Build a Report 


Mayer Brown Advises GW Pharmaceuticals on $289.8 Million Nasdaq Offering

The 10 Firms GCs Love For Pharma Work

Corporate & Securities partner Reb Wheeler (New York), and Intellectual Property partners James Ferguson and Joseph Mahoney (both Chicago) are quoted in this article discussing the 10 strongest firms for Pharmaceutical work.

Mayer Brown Advises Baxalta Incorporated on $1.45B Stock Offering

Mayer Brown Represents Nestlé Health Science in Major Biotech Licensing and Collaboration Transaction

We offer the legal and technical experience and global awareness needed to understand the opportunities offered and challenges presented to these industries.

Our Life Sciences group consists of a multidisciplinary team of lawyers with extensive industry knowledge and resources. The group comprises lawyers from across the firm’s practices. These lawyers are experienced in dealing with the issues affecting the life sciences industries globally, including: transactions, intellectual property (IP), dispute resolution, antitrust and competition, risk management, investigations and compliance, government and global trade, tax and transfer pricing, and regulatory and environmental matters.

At Mayer Brown, we have a long history of providing clients in these industry sectors with practical and effective legal support. Our clients range from start-ups to some of the largest life sciences companies in the world.

We also represent a significant number of regional, national and global banks, investment banks and other investors in capital markets and structured finance transactions relating to the life sciences industries.

Our geographic reach and on-the-ground presence in most of the world’s key business and finance centers allow us to assist our clients in structuring and coordinating cross-border transactions and other transnational legal matters. Our in-depth experience, gained by working across business areas and issues with life sciences companies and networking with leading industry organizations, provides our lawyers with the necessary insights for handling the legal and regulatory challenges facing these industries.

Our Life Sciences practice provides advice on the full range of issues, including:

  • Transactions
  • Intellectual Property
  • Hatch-Waxman Counseling & Litigation
  • Licensing
  • Dispute Resolution
  • FDA Regulatory
  • Antitrust and Competition
  • Risk Management, Investigations and Compliance
  • Government and Global Trade
  • Tax and Transfer Pricing
  • Regulatory and Environmental

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.